No Image

Deep Dive: Market Access

April 30, 2021 Auto Bot 0

It’s fair to say this is the most interesting time ever for market access. Not only has COVID forced companies, governments and healthcare systems to […]

No Image

Links

April 30, 2021 Auto Bot 0

Disability and distress. COVID-19 vaccine showdown: California vs. Texas. Opioid trajectories. “beliefs…are insufficiently skeptical about nondisclosed information in the absence of repeated feedback” What is […]

No Image

Pfizer to Acquire Amplyx Pharmaceuticals

April 29, 2021 Auto Bot 0

Through the acquisition, Pfizer will have access to Amplyx’s lead compound, Fosmanogepix (APX001), an investigational asset under development for the treatment of invasive fungal infections.